India: Prescription for growth

Posted AtHoneycombconnect.com

As international markets become more accessible and provide greater certainty around critical business factors such as intellectual property protection, these countries will become increasingly important to the success of global pharmaceutical manufacturers. The growth in opportunity that these markets represent is highlighted by the fact that China is expected to become the world's fourth largest consumer market for drugs by 2010.

Anticipating the impact of new markets on the industry, PricewaterhouseCoopers' Global Pharmaceutical Industry Group has published a series of market analyses called Prescription for Growth that explore the nature of the current drug market in these countries and assesses the future opportunities and challenges they offer.

October 14, 2005